Christine M Blasey

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction
    Christine M Blasey
    Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, United States
    Contemp Clin Trials 30:284-8. 2009
  2. doi request reprint Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats
    Joseph K Belanoff
    Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park, CA 94061, United States
    Eur J Pharmacol 655:117-20. 2011
  3. doi request reprint Mifepristone treatment of olanzapine-induced weight gain in healthy men
    Coleman Gross
    Corcept Therapeutics, Menlo Park, CA 94025, USA
    Adv Ther 26:959-69. 2009

Detail Information

Publications3

  1. doi request reprint A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction
    Christine M Blasey
    Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, United States
    Contemp Clin Trials 30:284-8. 2009
    ....
  2. doi request reprint Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats
    Joseph K Belanoff
    Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park, CA 94061, United States
    Eur J Pharmacol 655:117-20. 2011
    ..Both glucocorticoid receptor antagonists significantly attenuated the weight gain induced by olanzapine in a dose dependent manner. Differences in weight gain were not attributable to decreased food intake...
  3. doi request reprint Mifepristone treatment of olanzapine-induced weight gain in healthy men
    Coleman Gross
    Corcept Therapeutics, Menlo Park, CA 94025, USA
    Adv Ther 26:959-69. 2009
    ..The objective of this study was to determine if mifepristone, a glucocorticoid receptor antagonist, could prevent olanzapine-induced weight gain...